Publications by authors named "L D Swaim"
Article Synopsis
- Intrinsic breast cancer molecular subtyping (IBCMS) is important for predicting outcomes and guiding treatment in breast cancer patients.
- This study evaluated various IBCMS methods and gene-expression platforms in two clinical trials (PALOMA-2 and PALLET) and found differing levels of agreement in molecular subtype assignments.
- The results emphasize the need for standardized approaches in IBCMS to avoid potential misguidance in treatment decisions.
Article Synopsis
- The transition from whole-cell pertussis (wP) vaccines to acellular pertussis (aP) vaccines in the US began in 1997, raising questions about infant protection following maternal Tdap vaccination during pregnancy.
- A study compared the levels of pertussis-specific antibodies in infants born to mothers who received Tdap, based on whether their childhood vaccine was aP or wP, involving 253 infants from aP-primed mothers and 506 from wP-primed ones.
- Results showed that infants of aP-primed mothers had significantly lower levels of critical antibodies for preventing severe pertussis, suggesting that maternal Tdap vaccination might be less effective in providing protection for infants of a
Background: Kinetics of Tdap-induced maternally-derived antibodies in infants are poorly understood. Pre-Tdap era data suggest that maternal pertussis antibodies in infants have a half-life of approximately 5-6 weeks.
Methods: 34 mother-infant pairs had blood collected before maternal Tdap vaccination, 4 weeks later, at delivery (maternal and cord), and at infant ages 3 and 6 weeks from June 2014-March 2015.
Objective: To estimate the rate of readmissions for postpartum venous thromboembolism (VTE) during the first 30 days postdelivery between women with and without the immediate postpartum insertion of the etonogestrel contraceptive implant.
Methods: The Nationwide Readmissions Database from 2016 was used to identify women with a singleton delivery, immediate postpartum insertion of the etonogestrel contraceptive implant, and readmission for VTE within 30 days of discharge. Those with a prior history of VTE or anticoagulant therapy were excluded.
Coronavirus disease 2019 (COVID-19) has been declared a public health emergency for the entire United States. Providing access to prenatal health care while limiting exposure of both obstetric health care professionals and patients to COVID-19 is challenging. Although reductions in the frequency of prenatal visits and implementation of telehealth interventions provide some options, there still remains a need for patient-health care professional visits.
View Article and Find Full Text PDF